Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our customタンパク質 services!
カスタムサービスについてのお問い合わせはこちら >>
Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service？ Thank you for choosing ACROBiosystems. Would you rate our product and service？
Here come GMP Grade Cytokines！Free Sample is available！ Here come GMP Grade Cytokines！Free Sample is available！
| Project Name | Project Stage | Molecule Type | Host Species | Therapeutic Area | Indications |
| ALPP/ALPPL2 mAb - 01 | PCC | Solid Tumor | Endometrial cancer,Ovarian cancer |
Immobilized Human ALPG, His Tag (Cat. No. ALG-H52H9) at 1 μg/mL (100 μL/well) can bind Anti - ALPG / ALPPL2 with a linear range of 0.002-0.125 μg/mL (QC tested).
The purity of Biotinylated Human ALPG Protein, His,Avitag (Cat. No. ALG-H52E1) is more than 90% and the molecular weight of this protein is around 115-135kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Amifostine | NSC-296961; YM-08310; S-8744; SAPEP; WR-2721; WR-2721C | Approved | Medimmune Llc | 天地达, 安福定, Ethyol | United States | Head and Neck Neoplasms; Ovarian Neoplasms | Clinigen Inc | 1995-12-08 | Cytoprotective adjuvant; Myelodysplastic-Myeloproliferative Diseases; Salivary Gland Diseases; Mucositis; Lymphoma; Lymphoma, Non-Hodgkin; Lung Neoplasms; Bone Marrow Diseases; Sarcoma; Acute Radiation Syndrome; Breast Neoplasms; Prostatic Neoplasms; Gestational Trophoblastic Disease; Radiation Injuries; Head and Neck Neoplasms; Nasopharyngeal Neoplasms; Fanconi Anemia; Hodgkin Disease; Small Cell Lung Carcinoma; Myelodysplastic Syndromes; Neutropenia; Carcinoma; Peripheral Nervous System Diseases; Trigeminal Neuralgia; Solid tumours; Ovarian Neoplasms; Drug-Related Side Effects and Adverse Reactions | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| ALXN-1850 | ALXN-1850 | Phase 3 Clinical | Alexion Pharmaceuticals Inc | Hypophosphatasia | Details |
This web search service is supported by Google Inc.
アクロバイオシステムズの公式アカウント
A-Z
